Tumour endothelial cells in high metastatic tumours promote metastasis via epigenetic dysregulation of biglycan
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tumour endothelial cells in high metastatic tumours promote metastasis via epigenetic dysregulation of biglycan
Authors
Keywords
-
Journal
Scientific Reports
Volume 6, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-06-13
DOI
10.1038/srep28039
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- ADAMTS-4 and Biglycan are Expressed at High Levels and Co-Localize to Podosomes During Endothelial Cell Tubulogenesis In Vitro
- (2013) Masanari Obika et al. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
- Tumor Endothelial Cells Acquire Drug Resistance by MDR1 Up-Regulation via VEGF Signaling in Tumor Microenvironment
- (2012) Kosuke Akiyama et al. AMERICAN JOURNAL OF PATHOLOGY
- Heterogeneity of Tumor Endothelial Cells
- (2012) Noritaka Ohga et al. AMERICAN JOURNAL OF PATHOLOGY
- Biglycan is a specific marker and an autocrine angiogenic factor of tumour endothelial cells
- (2012) K Yamamoto et al. BRITISH JOURNAL OF CANCER
- CXCR7: A novel tumor endothelial marker in renal cell carcinoma
- (2012) Nako Maishi et al. PATHOLOGY INTERNATIONAL
- HuR keeps an angiogenic switch on by stabilising mRNA of VEGF and COX-2 in tumour endothelium
- (2011) T Kurosu et al. BRITISH JOURNAL OF CANCER
- Identification of Genes Upregulated in ALK-Positive and EGFR/KRAS/ALK-Negative Lung Adenocarcinomas
- (2011) H. Okayama et al. CANCER RESEARCH
- Differential vitamin D 24-hydroxylase/CYP24A1gene promoter methylation in endothelium from benign and malignant human prostate
- (2011) Kristin K. Deeb et al. Epigenetics
- TGF-β stimulates biglycan core protein synthesis but not glycosaminoglycan chain elongation via Akt phosphorylation in vascular smooth muscle
- (2011) Narin Osman et al. GROWTH FACTORS
- Initial steps of metastasis: Cell invasion and endothelial transmigration
- (2011) Franziska van Zijl et al. MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH
- Isolated tumor endothelial cells maintain specific character during long-term culture
- (2010) Kohei Matsuda et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- TGF-β stimulates biglycan synthesis via p38 and ERK phosphorylation of the linker region of Smad2
- (2010) Micah L. Burch et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Proteoglycans in health and disease: novel regulatory signaling mechanisms evoked by the small leucine-rich proteoglycans
- (2010) Renato V. Iozzo et al. FEBS Journal
- Cytogenetic Abnormalities of Tumor-Associated Endothelial Cells in Human Malignant Tumors
- (2009) Tomoshige Akino et al. AMERICAN JOURNAL OF PATHOLOGY
- PrognoScan: a new database for meta-analysis of the prognostic value of genes
- (2009) Hideaki Mizuno et al. BMC Medical Genomics
- Inhibitory effects of epigallocatechin-3 gallate, a polyphenol in green tea, on tumor-associated endothelial cells and endothelial progenitor cells
- (2009) Noritaka Ohga et al. CANCER SCIENCE
- Metastasis-Associated Gene Expression Changes Predict Poor Outcomes in Patients with Dukes Stage B and C Colorectal Cancer
- (2009) R. N. Jorissen et al. CLINICAL CANCER RESEARCH
- Biglycan, a Danger Signal That Activates the NLRP3 Inflammasome via Toll-like and P2X Receptors
- (2009) Andrea Babelova et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Transcription factor 8 activates R-Ras to regulate angiogenesis
- (2008) Takayuki Inuzuka et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Understanding tumor endothelial cell abnormalities to develop ideal anti-angiogenic therapies
- (2008) Kyoko Hida et al. CANCER SCIENCE
- Biglycan Is Required for Adaptive Remodeling After Myocardial Infarction
- (2008) D. Westermann et al. CIRCULATION
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started